World CB & CDx Summit Europe 2026

London, UK
March 30, 2026 – April 1, 2026

Discovery Life Sciences is proud to be exhibiting (Booth #5) at this year’s Clinical Biomarkers & Companion Diagnostics Summit Europe in London, March 30–April 1. We’re also featured in the conference program with a presentation in the Rx–Dx Commercialisation & Adoption track. More details on our presentation can be found below.

About the Event:

The 16th World Clinical Biomarkers & Companion Diagnostics Summit Europe returns as the region’s leading precision medicine forum, uniting 300+ senior experts across biopharma, diagnostics, regulation, reimbursement, and healthcare to advance biomarker strategy and accelerate drug–diagnostic market readiness.

Featured Presentation: 
Tuesday, March 31 |  5:20 p.m.

A Four-Year Journey Utilizing In-House Devices for Clinical Trials
T. Scott Reid, VP and Global Head of Companion Diagnostics, Discovery Life Sciences

  • Implementation of IVDR in 2022 strictly limited the use of lab-developed tests (LDTs) in clinical trials
  • Discovery Life Sciences’ Kassel, Germany, facility is a qualified Health Institution and has 4 years of experience utilizing LDTs to support patient management in EU clinical trials under IVDR
  • Discovery’s approach to developing clinical trial assays (CTA) under this system will be discussed,  along with illustrative case studies

Schedule a Meeting at World CB & CDx Summit Europe 2026

Quick Links
Privacy Settings